These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Medical treatment of epithelial ovarian cancer. González-Martín AJ Expert Rev Anticancer Ther; 2004 Dec; 4(6):1125-43. PubMed ID: 15606338 [TBL] [Abstract][Full Text] [Related]
3. Recent advances in the management of women with ovarian cancer. Eltabbakh GH Minerva Ginecol; 2004 Feb; 56(1):81-9. PubMed ID: 14973412 [TBL] [Abstract][Full Text] [Related]
4. [Neoadjuvant chemotherapy for advanced epithelial ovarian cancer]. Hatae M; Onishi Y; Nakamura T; Yamamoto H; Kusumoto M; Matsui T; Mihara K; Taniguchi H Gan To Kagaku Ryoho; 2001 Nov; 28(12):1833-7. PubMed ID: 11729475 [TBL] [Abstract][Full Text] [Related]
5. Update on the management of ovarian cancer. Ozols RF Cancer J; 2002; 8 Suppl 1():S22-30. PubMed ID: 12075699 [TBL] [Abstract][Full Text] [Related]
7. [Latest information in the diagnoses of ovarian carcinoma]. Isonishi S Gan To Kagaku Ryoho; 2002 Aug; 29(8):1351-7. PubMed ID: 12214460 [TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease. Hou JY; Kelly MG; Yu H; McAlpine JN; Azodi M; Rutherford TJ; Schwartz PE Gynecol Oncol; 2007 Apr; 105(1):211-7. PubMed ID: 17239941 [TBL] [Abstract][Full Text] [Related]
9. Advanced ovarian cancer: a clinical update on first-line treatment, recurrent disease, and new agents. Ozols RF J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S60-73. PubMed ID: 19780247 [TBL] [Abstract][Full Text] [Related]
10. [Ovarian carcinoma: current therapeutic aspects. A review]. Buser K; Hänggi W; Greiner R; Schatzmann E Schweiz Med Wochenschr; 1990 Nov; 120(44):1617-32. PubMed ID: 2251477 [TBL] [Abstract][Full Text] [Related]
12. Four cycles of paclitaxel and carboplatin as adjuvant treatment in early-stage ovarian cancer: a six-year experience of the Hellenic Cooperative Oncology Group. Bamias A; Papadimitriou C; Efstathiou E; Rodolakis A; Vlahos G; Voulgaris Z; Bozas G; Fountzilas G; Aravantinos G; Razis E; Gika D; Dimopoulos MA BMC Cancer; 2006 Sep; 6():228. PubMed ID: 16999858 [TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy for recurrent ovarian cancer]. Nishimura H; Imamura K; Chang C Gan To Kagaku Ryoho; 1996 Aug; 23(9):1124-8. PubMed ID: 8751798 [TBL] [Abstract][Full Text] [Related]
14. [Treatment of ovarian cancer]. Cianti C Clin Ter; 2002; 153(2):135-44. PubMed ID: 12078339 [TBL] [Abstract][Full Text] [Related]
15. Chemotherapy for ovarian cancer: an evidence-based approach. Geisler JP; Manahan KJ; Wiemann MC Minerva Ginecol; 2004 Dec; 56(6):539-45. PubMed ID: 15729206 [TBL] [Abstract][Full Text] [Related]
16. Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma. Safra T; Menczer J; Bernstein RM; Shpigel S; Matcejevsky D; Inbar MJ; Golan A; Grisaru D; Levy T Gynecol Oncol; 2009 Aug; 114(2):215-8. PubMed ID: 19446318 [TBL] [Abstract][Full Text] [Related]
17. Intraperitoneal cisplatin and paclitaxel versus intravenous carboplatin and paclitaxel chemotherapy for Stage III ovarian cancer: a cost-effectiveness analysis. Bristow RE; Santillan A; Salani R; Diaz-Montes TP; Giuntoli RL; Meisner BC; Armstrong DK; Frick KD Gynecol Oncol; 2007 Sep; 106(3):476-81. PubMed ID: 17688927 [TBL] [Abstract][Full Text] [Related]
18. Surgical cytoreduction in recurrent ovarian carcinoma in patients with complete response to paclitaxel-platinum. Gronlund B; Lundvall L; Christensen IJ; Knudsen JB; Høgdall C Eur J Surg Oncol; 2005 Feb; 31(1):67-73. PubMed ID: 15642428 [TBL] [Abstract][Full Text] [Related]
19. Should intraperitoneal chemotherapy be considered as standard first-line treatment in advanced stage ovarian cancer? Petignat P; du Bois A; Bruchim I; Fink D; Provencher DM Crit Rev Oncol Hematol; 2007 May; 62(2):137-47. PubMed ID: 17188887 [TBL] [Abstract][Full Text] [Related]
20. For women receiving chemotherapy for clinically apparent early ovarian cancer, is there a benefit to surgical staging? Dizon DS; Restivo A; Lomme M; Charbonneau N; Brard L; Hughes T; Weitzen S; Legare R; Granai CO; Disilvestro P Am J Clin Oncol; 2008 Feb; 31(1):39-42. PubMed ID: 18376226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]